.svg){kind=small}
Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Quality Drugs has shown consistent performance in the Edible category in Oregon, maintaining a steady 12th place ranking from July through October 2024. This stability is noteworthy, especially as the brand navigates a competitive market landscape. Despite a slight dip in sales in September, with sales dropping to $84,575, the brand quickly rebounded in October, achieving sales of $97,210. This indicates a strong ability to recover and suggests effective strategies in place to maintain consumer interest and market share.
Interestingly, in states and categories where Quality Drugs did not appear in the top 30, it indicates either a lack of presence or competitive challenges that the brand might be facing. This absence could be perceived as a potential area for growth or a strategic decision to focus resources elsewhere. Understanding these dynamics can provide deeper insights into the brand's overall market strategy and its adaptability in various regions. However, without specific rankings from other states or categories, it’s challenging to draw a comprehensive picture of their nationwide performance.
Competitive Landscape
In the competitive landscape of the Oregon edible cannabis market, Quality Drugs consistently maintained a stable rank of 12th place from July to October 2024. This stability is noteworthy, especially when compared to competitors like Sour Bhotz, which experienced a decline in rank from 9th to 11th over the same period, and Mr. Moxey's, which fluctuated but remained in the top 10. Quality Drugs' sales showed resilience, with a slight dip in September but recovering in October, closely mirroring the sales of Mr. Moxey's and outperforming beaucoup and Feel Goods, both of which remained consistently lower in rank and sales. This consistent performance suggests that Quality Drugs has a solid foothold in the market, maintaining its position amidst fluctuating sales and rankings of its competitors.
Notable Products
In October 2024, the top-performing product from Quality Drugs was the Cherry Lime & Blue Raspberry Cosmic Pop Gummy (100mg), maintaining its first-place rank consistently since July, despite a sales decline to 3833 units. The Mango Gummy (100mg) rose to second place, overtaking the Watermelon Gummy (100mg) which dropped to third. New to the top rankings is the CBD/CBN/THC 1:1:1 Wildberry Tea Chamomile Gumdrops 20-Pack, entering at fourth place with 1013 units sold. The Lime Gummy (100mg) held steady at fifth place throughout the months. These shifts highlight a dynamic edible category where consumer preferences are evolving, with notable movement in the ranks for the first time in several months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
